Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis

Objective: Administration of drugs targeting anti-cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) is often associated with serious immune-related adverse events (irAEs). Here, we performed a comprehensive analysis of organ-specific irAEs and treatment-related hematologic abnormalities and muscu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hang, Tan, Ping, Zheng, Xiaonan, Huang, Yu, Lin, Tianhai, Wei, Qiang, Ai, Jianzhong, Yang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613615/
https://www.ncbi.nlm.nih.gov/pubmed/31308633
http://dx.doi.org/10.2147/DDDT.S196316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613615/
https://www.ncbi.nlm.nih.gov/pubmed/31308633
http://dx.doi.org/10.2147/DDDT.S196316

Ejemplares similares